1. Home
  2. VC vs OGN Comparison

VC vs OGN Comparison

Compare VC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$103.96

Market Cap

3.2B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.16

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
OGN
Founded
2000
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.7B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
VC
OGN
Price
$103.96
$7.16
Analyst Decision
Strong Buy
Hold
Analyst Count
13
5
Target Price
$129.08
$14.10
AVG Volume (30 Days)
311.9K
4.8M
Earning Date
10-23-2025
11-10-2025
Dividend Yield
1.06%
1.11%
EPS Growth
N/A
N/A
EPS
11.17
1.91
Revenue
$3,759,000,000.00
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.92
N/A
P/E Ratio
$9.33
$3.75
Revenue Growth
N/A
N/A
52 Week Low
$65.10
$6.18
52 Week High
$129.10
$17.23

Technical Indicators

Market Signals
Indicator
VC
OGN
Relative Strength Index (RSI) 50.81 43.82
Support Level $98.57 $6.90
Resistance Level $103.38 $7.49
Average True Range (ATR) 2.48 0.30
MACD 0.73 0.03
Stochastic Oscillator 72.42 25.65

Price Performance

Historical Comparison
VC
OGN

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: